Treatment of patients with acute myocardial infarction with intravenous magnesium.
Acute myocardial infarction (AMI) accounts for a large number of deaths annually. The major cause of early deaths is ventricular fibrillation. During the past few years, intravenous magnesium has been instituted as a therapy for AMI. This report reviews the latter literature and discusses the potential mechanisms whereby intravenous Mg is beneficial in AMI. Intravenous Mg is a safe and inexpensive drug whose use reduces the incidence of arrhythmias, infarct size and early mortality following AMI.
Abraham
A S
AS
Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000008:administration & dosage* / Q000502:physiology; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality
D008274:Magnesium